Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53,457Revenue $M2,820Net Margin (%)11.7Altman Z-Score27.8
Enterprise Value $M53,089EPS $3.1Operating Margin %30.6Piotroski F-Score4
P/E(ttm)165Beneish M-Score-2.5Pre-tax Margin (%)28.6Higher ROA y-yN
Price/Book18.010-y EBITDA Growth Rate %--Quick Ratio4.1Cash flow > EarningsY
Price/Sales19.35-y EBITDA Growth Rate %--Current Ratio4.3Lower Leverage y-yY
Price/Free Cash Flow268y-y EBITDA Growth Rate %9.3ROA % (ttm)9.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)14.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M103ROIC % (ttm)17.5Gross Margin Increase y-yN

Gurus Latest Trades with REGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNKen Fisher 2015-03-31 Add$396.89 - $488.87
($423.8)
$ 517.6122%Add 1.91%534
REGNVanguard Health Care Fund 2014-12-31 Add0.12%$328.07 - $434.95
($393.59)
$ 517.6132%Add 4.49%2,921,000
REGNJoel Greenblatt 2014-12-31 Sold Out -0.01%$328.07 - $434.95
($394.04)
$ 517.6131%Sold Out0
REGNJoel Greenblatt 2014-09-30 Add$296.41 - $364.41
($335.27)
$ 517.6154%Add 60.05%1,410
REGNKen Fisher 2014-09-30 Buy $296.41 - $364.41
($335.27)
$ 517.6154%New holding583
REGNVanguard Health Care Fund 2014-06-30 Add0.79%$277.29 - $313.74
($296.6)
$ 517.6175%Add 60.34%2,795,500
REGNJoel Greenblatt 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 517.6175%New holding881
REGNMario Gabelli 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 517.6175%New holding2,295
REGNVanguard Health Care Fund 2014-03-31 Add0.29%$267.62 - $347.62
($306.26)
$ 517.6169%Add 23.47%1,743,468
REGNRon Baron 2014-03-31 Buy 0.01%$267.62 - $347.62
($307.2)
$ 517.6168%New holding6,084
REGNJoel Greenblatt 2013-12-31 Sold Out -0.03%$261.88 - $313.67
($287.35)
$ 517.6180%Sold Out0
REGNJoel Greenblatt 2013-09-30 Buy 0.03%$227.65 - $309.174
($262.76)
$ 517.6197%New holding3,285
REGNVanguard Health Care Fund 2013-03-31 Add0.62%$158.42 - $183.77
($171.66)
$ 517.61202%Add 170.41%1,412,100
REGNVanguard Health Care Fund 2012-09-30 Reduce-0.09%$112.77 - $152.66
($135.2)
$ 517.61283%Reduce 24.56%522,200
REGNDodge & Cox 2012-03-31 Sold Out $57.83 - $119.96
($92.23)
$ 517.61461%Sold Out0
REGNCarl Icahn 2011-09-30 Sold Out -1.76%$44.96 - $72.19
($58.66)
$ 517.61782%Sold Out0
REGNDodge & Cox 2011-09-30 Reduce-0.03%$44.96 - $72.19
($58.66)
$ 517.61782%Reduce 97.62%9,400
REGNVanguard Health Care Fund 2011-09-30 Add0.03%$44.96 - $72.19
($58.22)
$ 517.61789%Add 15.37%692,200
REGNDodge & Cox 2011-03-31 Buy 0.02%$32.61 - $44.68
($36.41)
$ 517.611322%New holding375,685
REGNVanguard Health Care Fund 2011-03-31 Reduce$32.61 - $44.94
($36.59)
$ 517.611315%Reduce 3.21%600,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOLDSTEIN JOSEPH LDirector 2015-06-22Sell2,000$526.85-2.77view
SING GEORGE LDirector 2015-05-27Sell5,000$515-0.54view
INGRAM ROBERT ALEXANDERDirector 2015-05-27Sell1,379$513.39-0.22view
Van Plew Daniel PSVP & General Mgr Industrial O 2015-05-26Sell18,370$508.420.75view
McCorkle Douglas SVP Controller and Asst Treasur 2015-05-22Sell13,000$515.6-0.65view
GOLDSTEIN JOSEPH LDirector 2015-05-22Sell4,000$514.28-0.4view
BROWN MICHAEL SDirector 2015-05-15Sell5,000$4953.48view
BAKER CHARLES ADirector 2015-03-25Sell5,000$454.9612.59view
Aberman Michael SSVP Strategy Investor Relation 2015-03-24Sell4,843$478.996.94view
Aberman Michael SSVP Strategy Investor Relation 2015-03-18Sell3,442$46510.16view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
Brean Capital Weighs in on Medivation Following Update on TERRAIN Study Mar 26 2015 
1 Feb 23 2015 
1 Feb 23 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
Weekly Insider Sells Highlight: REGN, HSP, TYC, AAPL Nov 30 2014 
S&P 500 Finishes Above 2,000 Aug 27 2014 
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
Weekly Insider Sells Highlight: MSFT, REGN, ATVI, MAA Feb 17 2014 
Insiders Are Buying Ophthotech Oct 08 2013 

More From Other Websites
5 Big Upcoming FDA Decisions Expected in July Jul 07 2015
What Is Beyond Vision-Loss Blockbuster For Regeneron? Jul 01 2015
Robbins Arroyo LLP Is Investigating Regeneron Pharmaceuticals, Inc. (REGN) Officials on Behalf of... Jul 01 2015
10 Best S&P 500 Health Care Stocks Jul 01 2015
New Film Documents Heart Felt Stories of People Living with High LDL Cholesterol Jun 30 2015
Regeneron/Bayer's Eylea Gets Label Expansion in Japan - Analyst Blog Jun 29 2015
Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the... Jun 29 2015
Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the... Jun 29 2015
WEEKEND VIDEO: Market Positives and Negatives Jun 27 2015
EYLEA® (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein... Jun 26 2015
Regeneron Announces 2015 Winners of the Regeneron Prize for Creative Innovation Jun 25 2015
Regeneron Announces 2015 Winners of the Regeneron Prize for Creative Innovation Jun 25 2015
Veteran Investor Sam Isaly Picks Top Biotechs Jun 23 2015
5 Biotech Stocks to Trade for Gains Jun 23 2015
Weekend Market VIDEO: Apple, Stocks to Watch, and Biotech Jun 21 2015
IBD Market Wrap - 06/18/15 Jun 18 2015
Fitbit surges on debut; Oracle slumps after earnings Jun 18 2015
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 17 2015
Why Avalanche's Disappointing Trial is Good News for Regeneron Jun 16 2015
Edited Transcript of REGN shareholder or annual meeting 12-Jun-15 2:30pm GMT Jun 16 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK